|
KR20200046050A
|
|
Antibody conjugation method
|
|
NZ711611A
|
|
Compositions and methods of use for determination of he4a
|
|
AU2011359350A1
|
|
Compositions and methods of use for determination of HE4a
|
|
WO2008121391A2
|
|
Use of he4 for assessment of breast cancers
|
|
US2006014221A1
|
|
Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma
|
|
US2006014211A1
|
|
Detection of mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of the peritoneum and the peritoneal cavity
|
|
US2004180387A1
|
|
Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer
|
